Caxton Associates LP Adma Biologics, Inc. Transaction History
Caxton Associates LP
- $3.12 Billion
- Q4 2024
A detailed history of Caxton Associates LP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Caxton Associates LP holds 51,568 shares of ADMA stock, worth $796,209. This represents 0.03% of its overall portfolio holdings.
Number of Shares
51,568
Previous 75,848
32.01%
Holding current value
$796,209
Previous $1.52 Million
41.69%
% of portfolio
0.03%
Previous 0.06%
Shares
8 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$288 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$281 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$230 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$174 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$85.5 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.03B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...